Insider trading

Period: 120 months Stock: TVTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

352 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

352 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

352 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

352 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
352 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
352 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

352 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2025
REED ELIZABETH E SVP, GC & CORPORATE SECRETARY
Sold on a plan
$177.05K 8,951 at 19.78
9.1%
Planned (10b5-1)
3 Feb 2025
ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D
Sold on a plan
$177.05K 8,951 at 19.78
8.6%
Planned (10b5-1)
3 Feb 2025
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$104.46K 5,192 at 20.12
5.5%
Not planned
3 Feb 2025
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$103.94K 5,166 at 20.12
4.0%
Not planned
3 Feb 2025
Inrig Jula CHIEF MEDICAL OFFICER
Sold on a plan
$84.64K 4,207 at 20.12
4.7%
Planned (10b5-1)
3 Feb 2025
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$67.36K 3,348 at 20.12
5.0%
Not planned
23 Jan 2025
Baynes Roy D. Director
Sold on a plan
$320.00K 16,000 at 20.00
34.0%
Planned (10b5-1)
22 Jan 2025
Dube Eric M CHIEF EXECUTIVE OFFICER
Sold on a plan
$208.92K 10,736 at 19.46
3.0%
Planned (10b5-1)
22 Jan 2025
REED ELIZABETH E SVP, GC & CORPORATE SECRETARY
Sold on a plan
$47.42K 2,437 at 19.46
3.1%
Planned (10b5-1)
22 Jan 2025
ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D
Sold on a plan
$47.42K 2,437 at 19.46
2.8%
Planned (10b5-1)
22 Jan 2025
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$30.00K 1,584 at 18.94
1.5%
Not planned
22 Jan 2025
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$17.52K 925 at 18.94
1.7%
Not planned
22 Jan 2025
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$16.38K 865 at 18.94
1.2%
Not planned
6 Jan 2025
Inrig Jula CHIEF MEDICAL OFFICER
Sold on a plan
$8.25K 440 at 18.76
0.7%
Planned (10b5-1)
3 Jan 2025
Inrig Jula CHIEF MEDICAL OFFICER
Sold on a plan
$39.46K 2,066 at 19.10
3.3%
Planned (10b5-1)
26 Dec 2024
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
$258.28K 15,000 at 17.22
21.5%
Planned (10b5-1)
25 Nov 2024
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$221.26K 12,090 at 18.30
18.0%
Not planned
4 Oct 2024
LYONS GARY A Director
Sold on a plan 2×
$589.10K 40,000 at 14.73
44.0%
Planned (10b5-1)
30 Sep 2024
Sold on a plan
$562.32K 40,000 at 14.06
33.1%
Planned (10b5-1)
10 Sep 2024
Inrig Jula CHIEF MEDICAL OFFICER
Sold on a plan
$8.88K 684 at 12.98
1.1%
Planned (10b5-1)
9 Sep 2024
Dube Eric M CHIEF EXECUTIVE OFFICER
Sold on a plan
$243.36K 21,125 at 11.52
5.5%
Planned (10b5-1)
9 Sep 2024
REED ELIZABETH E SVP, GC & CORPORATE SECRETARY
Sold on a plan
$50.54K 4,387 at 11.52
5.3%
Planned (10b5-1)
9 Sep 2024
ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D
Sold on a plan
$50.54K 4,387 at 11.52
4.9%
Planned (10b5-1)
9 Sep 2024
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$28.68K 2,490 at 11.52
3.2%
Not planned
9 Sep 2024
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$25.24K 2,191 at 11.52
2.0%
Not planned
9 Sep 2024
Inrig Jula CHIEF MEDICAL OFFICER
Sold at will
$25.24K 2,191 at 11.52
3.4%
Not planned
4 Sep 2024
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$4.89K 514 at 9.51
0.7%
Not planned
11 Apr 2024
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$363.96 54 at 6.74
0.1%
Not planned
1 Feb 2024
Dube Eric M CHIEF EXECUTIVE OFFICER
Sold at will 2×
$166.44K 19,122 at 8.70
5.2%
Not planned
1 Feb 2024
REED ELIZABETH E SVP, GC & CORPORATE SECRETARY
Sold at will 2×
$41.50K 4,764 at 8.71
5.9%
Not planned
1 Feb 2024
ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D
Sold at will 2×
$41.50K 4,764 at 8.71
5.6%
Not planned
1 Feb 2024
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$35.79K 4,195 at 8.53
4.0%
Not planned
1 Feb 2024
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$32.57K 3,818 at 8.53
5.1%
Not planned
1 Feb 2024
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$24.06K 2,820 at 8.53
5.1%
Not planned
1 Feb 2024
Inrig Jula CHIEF MEDICAL OFFICER
Sold at will
$18.55K 2,174 at 8.53
3.6%
Not planned
23 Jan 2024
Dube Eric M CHIEF EXECUTIVE OFFICER
Sold at will
$70.54K 7,873 at 8.96
3.2%
Not planned
23 Jan 2024
ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D
Sold at will
$18.48K 2,062 at 8.96
3.3%
Not planned
23 Jan 2024
REED ELIZABETH E SVP, GC & CORPORATE SECRETARY
Sold at will
$18.48K 2,062 at 8.96
3.5%
Not planned
23 Jan 2024
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$14.14K 1,559 at 9.07
1.9%
Not planned
23 Jan 2024
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$8.25K 910 at 9.07
2.2%
Not planned
23 Jan 2024
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$7.74K 853 at 9.07
1.7%
Not planned
4 Jan 2024
Inrig Jula Chief Medical Officer
Sold at will
$4.03K 440 at 9.17
1.2%
Not planned
3 Jan 2024
Inrig Jula Chief Medical Officer
Sold at will
$19.61K 2,069 at 9.48
5.5%
Not planned
3 Oct 2023
Heerma Peter Chief Commercial Officer
Sold at will
$25.50K 3,091 at 8.25
3.7%
Not planned
5 Sep 2023
Dube Eric M Chief Executive Officer
Sold at will
$65.53K 4,455 at 14.71
1.8%
Not planned
5 Sep 2023
ROTE WILLIAM E. Senior Vice President, R&D
Sold at will
$26.70K 1,815 at 14.71
2.9%
Not planned
5 Sep 2023
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold at will
$26.70K 1,815 at 14.71
3.0%
Not planned
5 Sep 2023
Cline Christopher R. Chief Financial Officer
Sold at will
$6.72K 457 at 14.71
0.9%
Not planned
11 May 2023
Calvin Sandra SVP, Chief Accounting Officer
Sold on a plan
$1.97K 122 at 16.12
0.3%
Planned (10b5-1)
10 May 2023
ROTE WILLIAM E. Senior Vice President, R&D
Sold on a plan
$13.69K 825 at 16.59
1.4%
Planned (10b5-1)
Showing 101–150 of 352. ← Newer Page 3 of 8 Older →